HK1232241A1 - 聚合物顆粒及其用途 - Google Patents

聚合物顆粒及其用途

Info

Publication number
HK1232241A1
HK1232241A1 HK17105924.1A HK17105924A HK1232241A1 HK 1232241 A1 HK1232241 A1 HK 1232241A1 HK 17105924 A HK17105924 A HK 17105924A HK 1232241 A1 HK1232241 A1 HK 1232241A1
Authority
HK
Hong Kong
Prior art keywords
polymer particles
particles
polymer
Prior art date
Application number
HK17105924.1A
Other languages
English (en)
Inventor
Bernd Helmut Adam Rehm
Bryce Malcolm Buddle
David Neil Wedlock
Original Assignee
Bernd Helmut Adam Rehm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernd Helmut Adam Rehm filed Critical Bernd Helmut Adam Rehm
Publication of HK1232241A1 publication Critical patent/HK1232241A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51Lyases (4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866Interferon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/555Interferons [IFN]
    • G01N2333/57IFN-gamma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
HK17105924.1A 2014-02-04 2017-06-14 聚合物顆粒及其用途 HK1232241A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ62068214 2014-02-04
PCT/NZ2015/050008 WO2015119512A1 (en) 2014-02-04 2015-02-04 Polymer particles and uses thereof

Publications (1)

Publication Number Publication Date
HK1232241A1 true HK1232241A1 (zh) 2018-01-05

Family

ID=53778236

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17105924.1A HK1232241A1 (zh) 2014-02-04 2017-06-14 聚合物顆粒及其用途

Country Status (13)

Country Link
US (1) US10501505B2 (zh)
EP (1) EP3102613B1 (zh)
CY (1) CY1124491T1 (zh)
DK (1) DK3102613T3 (zh)
ES (1) ES2891973T3 (zh)
HK (1) HK1232241A1 (zh)
HR (1) HRP20211418T1 (zh)
HU (1) HUE056108T2 (zh)
LT (1) LT3102613T (zh)
PL (1) PL3102613T3 (zh)
RS (1) RS62375B1 (zh)
SI (1) SI3102613T1 (zh)
WO (1) WO2015119512A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10684275B2 (en) 2016-12-14 2020-06-16 Becton, Dickinson And Company Methods and compositions for obtaining a tuberculosis assessment in a subject
CN109776662B (zh) * 2019-03-13 2022-05-17 中国动物卫生与流行病学中心 一种用于牛结核病变态反应检测的鸡尾酒抗原
CN109776661B (zh) * 2019-03-13 2022-08-09 中国动物卫生与流行病学中心 一种牛结核病γ-干扰素ELISA检测用鸡尾酒刺激抗原
CN109813576B (zh) * 2019-03-25 2021-04-02 中国动物卫生与流行病学中心 一种牛结核病刺激上清制备用采血器
CN109813884A (zh) * 2019-03-25 2019-05-28 中国动物卫生与流行病学中心 一种牛结核病γ-干扰素快速检测制品
CN111269297B (zh) * 2020-01-23 2021-11-30 郑州伊美诺生物技术有限公司 一种结核分枝杆菌刺激抗原的制备方法
WO2021207531A2 (en) * 2020-04-08 2021-10-14 Nanopin Technologies, Inc. Monoclonal antibodies and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722840A (en) * 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US20060024332A1 (en) * 2004-08-02 2006-02-02 Waters Wade R Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis
JP2009509530A (ja) * 2005-09-27 2009-03-12 ヘルムート アダム レフム,ベルン ポリマー粒子およびその使用
AU2010277222A1 (en) * 2009-07-29 2012-03-08 Bryce Malcolm Buddle Polymer particles and uses thereof
WO2012104791A1 (en) * 2011-02-01 2012-08-09 Bernd Helmut Adam Rehm Fusion polypeptides and uses thereof
WO2014009439A1 (en) * 2012-07-10 2014-01-16 Nec Europe Ltd. Reporting user related information in a mobile communication network

Also Published As

Publication number Publication date
EP3102613B1 (en) 2021-06-09
US20170008938A1 (en) 2017-01-12
HRP20211418T1 (hr) 2021-12-24
DK3102613T3 (da) 2021-09-13
CY1124491T1 (el) 2022-07-22
ES2891973T3 (es) 2022-02-01
RS62375B1 (sr) 2021-10-29
PL3102613T3 (pl) 2021-12-13
US10501505B2 (en) 2019-12-10
SI3102613T1 (sl) 2021-11-30
LT3102613T (lt) 2021-09-27
WO2015119512A1 (en) 2015-08-13
EP3102613A1 (en) 2016-12-14
HUE056108T2 (hu) 2022-01-28
EP3102613A4 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
IL249186B (en) Anti-cd20 glycoantibodies and their uses
HK1231471A1 (zh) -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途
IL247344A0 (en) A new polysaccharide and its uses
GB201405614D0 (en) Particles
HUE044571T2 (hu) Módosított ciklopentapeptidek és alkalmazásaik
GB201512725D0 (en) Polymeric particles
SG11201607082PA (en) New tetracyano-anthraquino-dimethane polymers and use thereof
EP3192815A4 (en) High-recoverability resin particles and use thereof
EP3357934B8 (en) Polymer particles and use thereof
HK1232241A1 (zh) 聚合物顆粒及其用途
SG11201704473WA (en) New methods and uses
GB201503393D0 (en) Polymers and uses thereof
EP3229842A4 (en) Lipocationic polymers and uses thereof
GB201412841D0 (en) Particles
EP3168250A4 (en) Fluorine-atom-containing polymer and use thereof
IL248014B (en) Nanostructures and their applications
GB2543713B (en) Polymeric proteins and uses thereof
SG10201501373WA (en) Contrast Agent And Applications Thereof
GB201408091D0 (en) Methods and uses
IL251518A0 (en) Astaxanthin-based polymers and their uses
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201407419D0 (en) Conductive materials and uses thereof
GB201416086D0 (en) Methods and uses
GB201416073D0 (en) Methods and uses
PT2923578T (pt) Método para a produção de um produto alimentar